Business Context and Reporting Period
This Form 8-K Current Report was filed by SANUWAVE Health, Inc. on June 7, 2019, covering events occurring on June 1, 2019. The Company is incorporated in Nevada and is classified as an emerging growth company. The report details a material definitive agreement regarding the extension of specific warrant expiration dates.
Key Financial Metrics
This filing does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. The document focuses exclusively on a corporate action regarding warrant terms.
Material Changes
On June 1, 2019, the Company amended the expiration dates of two classes of warrants:
- Class N Warrants: Expiration date extended from June 28, 2019, to September 3, 2019.
- Class O Warrants: Expiration date extended from June 28, 2019, to December 2, 2019.
Letters notifying holders of these extensions were sent on June 5, 2019. Certain Class O Warrants are held by members of the Board of Directors (Kevin Richardson, John Nemelka, Alan Rubino, Michael Stolarski, and Maj-Britt Kaltoft) and the Chief Financial Officer (Lisa Sundstrom).
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, or outlook. No specific risks or contingencies are discussed beyond the standard disclosure that the summary is qualified by reference to the full text of the Warrant Extension Letters and warrant forms filed as exhibits.
Investor Verification Checklist
- Verify the full terms of the Class N and Class O Warrant Extension Letters (Exhibits 4.1 and 4.2 to this filing).
- Review the original warrant agreements filed in prior 8-K reports (November 9, 2017, and March 15, 2019) to understand the baseline rights being modified.
- Confirm the impact of the extension on the Company's potential future dilution and capital structure.